Downregulation of Mitophagy, Complex I Biogenesis, and Signaling by ROBO Receptors-Implications for Psoriasis

Malin Assarsson1,2, Jan Söderman1,3, Olaf Dienus3

  • 1Department of Biomedical and Clinical Sciences, Faculty of Health Sciences, Linköping University, 581 83 Linköping, Sweden.

Insights

This study reveals altered cellular pathways in psoriasis, identifying downregulated mitophagy and respiratory electron transport, alongside upregulated SUMOylation and PIP synthesis in lesional skin. These findings offer new insights into psoriasis pathogenesis.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Immunology

Background:

  • Psoriasis pathogenesis involves complex, incompletely understood immunopathogenic mechanisms.
  • Identifying novel molecular pathways is crucial for understanding psoriasis development.

Purpose of the Study:

  • To identify novel pathways implicated in psoriasis pathogenesis.
  • To analyze differentially expressed genes and associated biological pathways in lesional and non-lesional skin compared to healthy controls.

Main Methods:

  • RNA sequencing was performed on skin biopsies from 23 psoriasis patients and 25 healthy controls.
  • Gene set enrichment analysis was employed to identify dysregulated biological pathways.
  • Comparisons were made between lesional skin, non-lesional skin, and healthy control skin.

Main Results:

  • Mitophagy and Respiratory Electron Transport pathways were downregulated in both lesional and non-lesional psoriasis skin compared to controls.
  • Signaling by ROBO receptors was downregulated across all comparisons.
  • SUMOylation pathways were upregulated in lesional skin versus non-lesional and control skin.
  • Pathways for PIP synthesis at the early endosome membrane were upregulated in lesional skin compared to control skin.

Conclusions:

  • Dysregulation of mitophagy, complex I biogenesis, ROBO receptor signaling, and PIP synthesis pathways suggests their potential involvement in psoriasis pathogenesis.
  • Further investigation into these pathways and protein expression is needed to confirm their role in psoriasis.
  • These findings highlight potential novel therapeutic targets for psoriasis treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K